Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
Quick Stats
Jun 23, 202660.5
AI Score
BUY0.87
Volume Ratio
Aug 05, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
KROS Stock Summary
Last updated Jun 23, 2026
KROS is currently trading at $11, positioned below its 200-day moving average of $14.91, suggesting bearish momentum. The stock has a 52-week range of $9.69 to $22.55.
Technical Analysis: The 50-day moving average stands at $11.05, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 55.334, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.148, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates KROS at 60.5/100 with a BUY recommendation.
KROS (Keros Therapeutics, Inc. Common Stock) Indicators
Last updated Jun 23, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 55.334 |
| CMF (20) | -0.148 |
| ROC (10) | 10.0 |
| ADX (14) | 14.967 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.122 |
| AROONOSC (14) | 50.0 |
| WILLAMS %R (14) | -25.143 |
| MFI (14) | 54.25 |
KROS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
KROS Price vs Max Options Open Interest
KROS Max Change In Options Open Interest
KROS Options - Sort by Max open Interest (near term)
24th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KROS Daily Out of Money Options - Sort by Max open Interest (near term)
24th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KROS Daily In the Money Options - Sort by Max open Interest (near term)
24th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KROS Most Active Options by Volume(near term)
24th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Keros Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
KROS Moving Averages Analysis
KROS (Keros Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jun 23, 2026
| Days | MA |
|---|---|
| 10 | 10.35 |
| 20 | 10.59 |
| 30 | 10.74 |
| 50 | 11.05 |
| 100 | 12.41 |
| 200 | 14.91 |
KROS Fundamental Analysis
| P/E (Forward) | 48.7805 |
| P/E (Trailing) | -- |
| Market Cap ($) | 217.3 million |
| Earnings/Share ($) | -2.53 |
| Net Proft Margin (%) | -2.566 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -5.186 |
| EPS Estimate Next Year ($) | -5.5933 |
| WallStreet Target Price ($) | 21.8333 |
| Most Recent Quarter |